ZA202108391B - Biomarkers for predicting progression of intravenous leiomyomatosis - Google Patents
Biomarkers for predicting progression of intravenous leiomyomatosisInfo
- Publication number
- ZA202108391B ZA202108391B ZA2021/08391A ZA202108391A ZA202108391B ZA 202108391 B ZA202108391 B ZA 202108391B ZA 2021/08391 A ZA2021/08391 A ZA 2021/08391A ZA 202108391 A ZA202108391 A ZA 202108391A ZA 202108391 B ZA202108391 B ZA 202108391B
- Authority
- ZA
- South Africa
- Prior art keywords
- biomarkers
- predicting progression
- intravenous leiomyomatosis
- leiomyomatosis
- intravenous
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
- G01N30/8624—Detection of slopes or peaks; baseline correction
- G01N30/8631—Peaks
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110715015 | 2021-06-25 | ||
| CN202110811846.3A CN113325117B (en) | 2021-06-25 | 2021-07-19 | Application of a group of biomarkers in preparation of kit for predicting progression of intravenous smooth sarcomatosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA202108391B true ZA202108391B (en) | 2022-02-23 |
Family
ID=77426505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2021/08391A ZA202108391B (en) | 2021-06-25 | 2021-10-29 | Biomarkers for predicting progression of intravenous leiomyomatosis |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN113325117B (en) |
| ZA (1) | ZA202108391B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114487201A (en) * | 2022-02-09 | 2022-05-13 | 江西省肿瘤医院(江西省第二人民医院、江西省癌症中心) | Application of detection reagent of nasopharyngeal carcinoma related urine marker combination |
| CN117007810B (en) * | 2023-06-12 | 2024-04-05 | 中国医学科学院北京协和医院 | Biomarker for predicting progression of intravenous smooth muscle tumor and application thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2443540T3 (en) * | 2007-07-17 | 2014-02-19 | Metabolon, Inc. | Biomarkers for pre-diabetes and methods that use them |
| WO2015157407A1 (en) * | 2014-04-08 | 2015-10-15 | Metabolon, Inc. | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment |
| CN105044361B (en) * | 2015-08-14 | 2017-07-28 | 山东省肿瘤防治研究院 | A kind of diagnostic marker and its screening technique for being suitable for esophageal squamous cell carcinoma early diagnosis |
| JP6583817B2 (en) * | 2015-09-04 | 2019-10-02 | 国立大学法人山口大学 | Diagnostic markers for tumors in uterine smooth muscle |
| CN108949989A (en) * | 2018-08-06 | 2018-12-07 | 中国医学科学院北京协和医院 | One group of biomarker is preparing the purposes in IVL detection, diagnosis or Prognosis scoveillance product |
-
2021
- 2021-07-19 CN CN202110811846.3A patent/CN113325117B/en active Active
- 2021-10-29 ZA ZA2021/08391A patent/ZA202108391B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN113325117B (en) | 2022-07-15 |
| CN113325117A (en) | 2021-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202108391B (en) | Biomarkers for predicting progression of intravenous leiomyomatosis | |
| EP3278113A4 (en) | Method for predicting risk of cognitive deterioration | |
| GB201817037D0 (en) | Selective depositon of metallic layers | |
| HK1249145A1 (en) | Prognostic biomarkers for ttk inhibitor chemotherapy | |
| IL284827A (en) | Biomarker panel for diagnosis and prognosis of cancer | |
| GB202108202D0 (en) | System for optimization of hydrocarbon production | |
| GB202014880D0 (en) | Detection of biomarkers | |
| EP4093513A4 (en) | Uses of biomarkers for improving immunotherapy | |
| EP4083627A4 (en) | Prognostic biomarker of cancer | |
| GB202007099D0 (en) | Tumour biomarkers for immunotherapy | |
| GB202103080D0 (en) | Cancer biomarkers | |
| GB202112705D0 (en) | Prostrate cancer biomarkers | |
| GB2583108B (en) | Installation of subsea risers | |
| EP3679160A4 (en) | Method of using biomarkers and clinical variables for predicting chemotherapy benefit | |
| EP3138923A4 (en) | Method for predicting prognosis of acute myeloid leukemia relapse | |
| GB202113759D0 (en) | Methods of cancer prognosis | |
| GB202117296D0 (en) | Method of prognosis | |
| GB202117299D0 (en) | Method of prognosis | |
| GB201918865D0 (en) | Adaptive media for approximation of blood biomarkers | |
| GB202016817D0 (en) | Multiplex Detection of Biomarkers | |
| GB202108791D0 (en) | Manufacture of pipelines | |
| GB202104287D0 (en) | Method for determining prognosis of chronic kidney disease | |
| GB202112831D0 (en) | Biomarker | |
| GB202110365D0 (en) | Biomarker | |
| GB202302965D0 (en) | Dedicated sub for look-ahead applications |